ÀÌ´ë¿©¼º¾Ïº´¿ø, ¡®¿©¼º¾Ï ½ÉÆ÷Áö¾ö¡¯ °³ÃÖ

ÀÌ°æÀÚ ¹æ»ç¼±Á¾¾çÇаú ±³¼ö, Á¤³â ÅðÀÓ ±â³ä Ưº°°­¿¬µµ ÁøÇà
´º½ºÀÏÀÚ: 2016³â01¿ù22ÀÏ 12½Ã23ºÐ

[º¸°ÇŸÀÓÁî] ÀÌ´ë¿©¼º¾Ïº´¿ø(º´¿øÀå ¹é³²¼±)Àº ÀÌ´ë¸ñµ¿º´¿ø 2Ãþ ´ëȸÀǽǿ¡¼­ ¿À´Â 29ÀÏ ¿ÀÈÄ 1½Ã 30ºÐºÎÅÍ 6½Ã±îÁö °³¿øÀǸ¦ ´ë»óÀ¸·Î ¿©¼º¾Ï ½ÉÆ÷Áö¾öÀ» °³ÃÖÇÑ´Ù.

À̹ø ½ÉÆ÷Áö¾öÀº ºÎÀξϰú À¯¹æ¾ÏÀ» ÁÖÁ¦·Î 2ºÎ·Î ³ª´©¾î ÁøÇàµÇ´Âµ¥ 1ºÎ¿¡¼­´Â ºÎÀξÏÀ» ÁÖÁ¦·Î ±è½Âö ÀÌÈ­ÀÇ·á¿øÀåÀÌ ÁÂÀåÀ» ¸Ã°í ÀÌ°æÀÚ ¹æ»ç¼±Á¾¾çÇаú ±³¼ö°¡ Á¤³âÅðÀÓÀ» ±â³äÇØ 'ÀڱðæºÎ¾ÏÀÇ ¹æ»ç¼± Ä¡·á:ÀÌÈ­ÀÇ·á¿øÀÇ ÀÓ»ó°æÇè'À» ÁÖÁ¦·Î Ưº° °­¿¬À» ÁøÇàÇϸç, À̾î ÁÖ¿õ ºÎÀÎÁ¾¾ç¼¾ÅÍÀåÀÇ 'Surgical Treatment of Gynecologic Cancer' °­¿¬ÀÌ ÁøÇàµÈ´Ù.

À̾î À¯¹æ¾ÏÀ» ÁÖÁ¦·Î ÇÑ 2ºÎ¿¡¼­´Â ¹é³²¼± ÀÌ´ë¿©¼º¾Ïº´¿øÀåÀÌ ÁÂÀåÀ» ¸Ã¾Æ Breast MRI’s Role in Practice(±èÁ¤Çö ¿µ»óÀÇÇаú ±³¼ö), Pathologic Evaluation of Postneoadjuvant Specimens in Breast Cancer(¼º¼øÈñ º´¸®°ú ±³¼ö), Axillary Management in Breast Cancer(ÀÌÁØ¿ì À¯¹æ¾Ï·°©»ó¼±¾Ï¼¾ÅÍ ±³¼ö), À¯¹æ¾Ï Àç°Ç¿¡ ÀÖ¾î õ°øÁö ÇÇÆÇÀÇ À¯¿ë¼º(¹Úº¸¿µ ¼ºÇü¿Ü°ú ±³¼ö) µîÀÇ °­¿¬ÀÌ À̾îÁø´Ù.

¶Ç, ¹®º´ÀÎ À¯¹æ¾Ï·°©»ó¼±¾Ï¼¾ÅÍÀåÀÌ ÁÂÀåÀ» À̾î¹Þ¾Æ Evidence Based Radiation Treatment for Early Breast Cancer(¹Ú°æ¶õ ¹æ»ç¼±Á¾¾çÇаú), Overview of the ER+ Breast Cancer and New Concept of Treatment(ÀÌ°æÀº Ç÷¾×Á¾¾ç³»°ú), À¯¹æ¾Ï ȯÀÚÀÇ ±Ù°ñ°Ý°è ÀçÈ°(ÇѼöÁ¤ ÀçÈ°ÀÇÇаú) µîÀÇ °­¿¬ÀÌ ÆîÃÄÁú ¿¹Á¤ÀÌ´Ù.

¹«·á·Î ÁøÇàµÇ´Â À̹ø ½ÉÆ÷Áö¾öÀº »çÀüµî·Ï ¾øÀÌ ´çÀÏ µî·ÏÀÌ °¡´ÉÇϸç Âü¿©¸¦ ¿øÇÏ´Â »ç¶÷Àº ÀÌ´ë¿©¼º¾Ïº´¿ø(02-2650-5331)À¸·Î ¹®ÀÇÇÏ¸é µÈ´Ù.

 


ÀÌ ´º½ºÅ¬¸®ÇÎÀº BKT´º½º{www.bktimes.net}¿¡¼­ ¹ßÃéµÈ ³»¿ëÀÔ´Ï´Ù.